Occult Pneumothoraces in Critical Care (OPTICC) is committed to advancing critical care through innovative research and development in Calgary. Our focus is on understanding and managing occult pneumothoraces, which are not typically suspected during clinical examinations.
We are currently conducting the OPTICC trial, which involves recruiting participants to evaluate treatment for patients with occult pneumothoraces. With a dedicated team of professionals led by Dr. Andrew Kirkpatrick, we aim to enhance patient outcomes through rigorous scientific study and local collaboration.
We are currently conducting the OPTICC trial, which involves recruiting participants to evaluate treatment for patients with occult pneumothoraces. With a dedicated team of professionals led by Dr. Andrew Kirkpatrick, we aim to enhance patient outcomes through rigorous scientific study and local collaboration.
